Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral imatinib for pulmonary arterial hypertension
ISRCTN94603622Phase 2Recruiting
- Sponsor
- Imperial College London
- Start
- Jan 2026
- Modality
- Small Molecules
01
Overview
Phase 2 trial of imatinib, sponsored by Imperial College London. Started Jan 2026; status: recruiting.
02
Drugs
Beyond the preview
Go deeper on ISRCTN94603622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN94603622.